Mersana Therapeutics, Inc. - Common Stock (MRSN)

Mersana Therapeutics is a biotechnology company focused on the development of innovative treatments for cancer

The company specializes in advancing antibody-drug conjugates (ADCs), which are targeted therapies designed to deliver potent cytotoxic agents directly to cancer cells while minimizing damage to healthy tissue. Mersana is dedicated to improving patient outcomes through its proprietary technology platform, which enables the design of highly effective treatments aimed at addressing various types of tumors. With a strong emphasis on research and development, the company is committed to bringing novel therapies to market that address unmet medical needs in the oncology space.